Abstract
Sudden unexpected death in epilepsy (SUDEP) is the most common cause of death directly related to epilepsy, and most frequently occurs in people with chronic epilepsy. The main risk factors for SUDEP are associated with poorly controlled seizures, suggesting that most cases of SUDEP are seizure-related events. Dysregulation in cardiac and respiratory physiology, dysfunction in systemic and cerebral circulation physiology, and seizure-induced hormonal and metabolic changes might all contribute to SUDEP. Cardiac factors include bradyarrhythmias and asystole, as well as tachyarrhythmias and alterations to cardiac repolarization. Altered electrolytes and blood pH, as well as the release of catecholamines, modulate cardiac excitability and might facilitate arrhythmias. Respiratory symptoms are not uncommon during seizures and comprise central apnea or bradypnea, and, less frequently, obstruction of the airways and neurogenic pulmonary edema. Alterations to autonomic function, such as a reduction in heart rate variability or disturbed baroreflex sensitivity, can impair the body's capacity to cope with challenging situations of elevated stress, such as seizures. Here, we summarize data on the incidence of and risk factors for SUDEP, and consider the pathophysiological aspects of chronic epilepsy that might lead to sudden death. We suggest that SUDEP is caused by the fatal coexistence of several predisposing and triggering factors.
Key Points
-
Sudden unexpected death in epilepsy (SUDEP) is the most frequent cause of death directly related to epilepsy, and most often occurs in individuals with chronic epilepsy
-
The most important risk factors for SUDEP are related to poorly controlled seizures, suggesting that SUDEP is a seizure-related event
-
Cardiac arrhythmia, respiratory dysfunction, dysregulation of systemic or cerebral circulation, and seizure-induced hormonal and metabolic changes have all been suggested as potential pathomechanisms in SUDEP
-
SUDEP is most probably triggered by the peri-ictal concurrence of a number of predisposing and precipitating factors
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bacon G. M. On the modes of death in epilepsy. Lancet 91, 555–556 (1868).
Nashef, L. Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia 38 (Suppl. 11), S6–S8 (1997).
Annegers, J. F. United States perspective on definitions and classifications. Epilepsia 38 (Suppl. 11), S9–S12 (1997).
Ficker, D. M. et al. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology 51, 1270–1274 (1998).
Téllez-Zenteno, J. F., Ronquillo, L. H. & Wiebe, S. Sudden unexpected death in epilepsy: evidence-based analysis of incidence and risk factors. Epilepsy Res. 65, 101–115 (2005).
Langan, Y., Nashef, L. & Sander, J. W. Sudden unexpected death in epilepsy: a series of witnessed deaths. J. Neurol. Neurosurg. Psychiatry 68, 211–213 (2000).
Hitiris, N. et al. Sudden unexpected death in epilepsy: a search for risk factors. Epilepsy Behav. 10, 138–141 (2007).
Nashef, L., Garner, S., Sander, J. W., Fish, D. R. & Shorvon, S. D. Circumstances of death in sudden death in epilepsy: interviews with bereaved relatives. J. Neurol. Neurosurg. Psychiatry 64, 349–352 (1998).
Nilsson, L., Farahmand, B. Y., Persson, P. G., Thiblin, I. & Tomson, T. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet 353, 888–893 (1999).
Beran, R. G., Weber, S., Sungaran, R., Venn, N. & Hung, A. Review of the legal obligations of the doctor to discuss sudden unexplained death in epilepsy (SUDEP)—a cohort controlled comparative cross-matched study in an outpatient epilepsy clinic. Seizure 13, 523–528 (2004).
Langan, Y., Nashef, L. & Sander, J. W. Case–control study of SUDEP. Neurology 64, 1131–1133 (2005).
Terrence, C. F., Rao, G. R. & Perper, J. A. Neurogenic pulmonary edema in unexpected, unexplained death of epileptic patients. Ann. Neurol. 9, 458–464 (1981).
Thom, M., Seetah, S., Sisodiya, S., Koepp, M. & Scaravilli, F. Sudden and unexpected death in epilepsy (SUDEP): evidence of acute neuronal injury using HSP-70 and c-Jun immunohistochemistry. Neuropathol. Appl. Neurobiol. 29, 132–143 (2003).
P-Codrea Tigaran, S., Dalager-Pedersen, S., Baandrup, U., Dam, M. & Vesterby-Charles, A. Sudden unexpected death in epilepsy: is death by seizures a cardiac disease? Am. J. Forensic Med. Pathol. 26, 99–105 (2005).
McKee, J. R. & Bodfish, J. W. Sudden unexpected death in epilepsy in adults with mental retardation. Am. J. Ment. Retard. 105, 229–235 (2000).
Walczak, T. S. et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 56, 519–525 (2001).
Timmings, P. L. Sudden unexpected death in epilepsy: a local audit. Seizure 2, 287–290 (1993).
Nilsson, L. et al. Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: a case-control study. Epilepsia 42, 667–673 (2001).
Walczak, T. Do antiepileptic drugs play a role in sudden unexpected death in epilepsy? Drug Saf. 26, 673–683 (2003).
Nashef, L., Fish, D. R., Garner, S., Sander, J. W. & Shorvon, S. D. Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty. Epilepsia 36, 1187–1194 (1995).
Yuen, A. W., Thompson, P. J., Flugel, D., Bell, G. S. & Sander, J. W. Mortality and morbidity rates are increased in people with epilepsy: is stress part of the equation? Epilepsy Behav. 10, 1–7 (2007).
Coronel, R. et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 112, 2769–2777 (2005).
Tan, H. L. et al. A sodium-channel mutation causes isolated cardiac conduction disease. Nature 409, 1043–1047 (2001).
Amin, A. S., Meregalli, P. G., Bardai, A., Wilde, A. A. & Tan, H. L. Fever increases the risk for cardiac arrest in the Brugada syndrome. Ann. Intern. Med. 149, 216–218 (2008).
Verkerk, A. O., van Ginneken, A. C., van Veen, T. A. & Tan, H. L. Effects of heart failure on brain-type Na+ channels in rabbit ventricular myocytes. Europace 9, 571–577 (2007).
Nashef, L., Hindocha, N. & Makoff, A. Risk factors in sudden death in epilepsy (SUDEP): the quest for mechanisms. Epilepsia 48, 859–871 (2007).
Stein, P. K. & Kleiger, R. E. Insights from the study of heart rate variability. Annu. Rev. Med. 50, 249–261 (1999).
Tomson, T., Ericson, M., Ihrman, C. & Lindblad, L. E. Heart rate variability in patients with epilepsy. Epilepsy Res. 30, 77–83 (1998).
Ronkainen, E. et al. Suppressed circadian heart rate dynamics in temporal lobe epilepsy. J. Neurol. Neurosurg. Psychiatry 76, 1382–1386 (2005).
Kloster, R. & Engelskjøn, T. Sudden unexpected death in epilepsy (SUDEP): a clinical perspective and a search for risk factors. J. Neurol. Neurosurg. Psychiatry 67, 439–444 (1999).
Diehl, B., Diehl, R. R., Stodieck, S. R. & Ringelstein, E. B. Spontaneous oscillations in cerebral blood flow velocities in middle cerebral arteries in control subjects and patients with epilepsy. Stroke 28, 2457–2459 (1997).
Hilz, M. J., Devinsky, O., Doyle, W., Mauerer, A. & Dütsch. M. Decrease of sympathetic cardiovascular modulation after temporal lobe epilepsy surgery. Brain 125, 985–995 (2002).
Evrengül, H. et al. Time and frequency domain analyses of heart rate variability in patients with epilepsy. Epilepsy Res. 63, 131–139 (2005).
Dütsch, M., Hilz, M. J. & Devinsky, O. Impaired baroreflex function in temporal lobe epilepsy. J. Neurol. 253, 1300–1308 (2006).
Mukherjee, S. et al. Cardiovascular autonomic functions in well-controlled and intractable partial epilepsies. Epilepsy Res. doi: 10.1016/j.eplepsyres.2009.03.021.
Dütsch, M., Devinsky, O., Doyle, W., Marthol, H. & Hilz, M. J. Cerebral autoregulation improves in epilepsy patients after temporal lobe surgery. J. Neurol. 251, 1190–1197 (2004).
Persson, H., Kumlien, E., Ericson, M. & Tomson, T. Preoperative heart rate variability in relation to surgery outcome in refractory epilepsy. Neurology 65, 1021–1025 (2005).
Druschky, A. et al. Interictal cardiac autonomic dysfunction in temporal lobe epilepsy demonstrated by [123I]metaiodobenzylguanidine-SPECT. Brain 124, 2372–2382 (2001).
Kerling, F. et al. Relation between ictal asystole and cardiac sympathetic dysfunction shown by MIBG-SPECT. Acta Neurol. Scand. doi:10.1111/j.1600–04042008.01135.x.
Hilz, M. J. et al. Outcome of epilepsy surgery correlates with sympathetic modulation and neuroimaging of the heart. J. Neurol. Sci. 216, 153–162 (2003).
Tisdale, J. E., Patel, R., Webb, C. R., Borzak, S. & Zarowitz, B. J. Electrophysiologic and proarrhythmic effects of intravenous inotropic agents. Prog. Cardiovasc. Dis. 38, 167–180 (1995).
Blumhardt, L. D., Smith, P. E. & Owen, L. Electrocardiographic accompaniments of temporal lobe epileptic seizures. Lancet 327, 1051–1056 (1986).
Natelson, B. H., Suarez, R. V., Terrence, C. F. & Turizo, R. Patients with epilepsy who die suddenly have cardiac disease. Arch. Neurol. 55, 857–860 (1998).
Opeskin, K., Thomas, A. & Berkovic, S. F. Does cardiac conduction pathology contribute to sudden unexpected death in epilepsy? Epilepsy Res. 40, 17–24 (2000).
Akashi, Y. J., Goldstein, D. S., Barbaro, G. & Ueyama, T. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation 118, 2754–2762 (2008).
Chin, P. S., Branch, K. R. & Becker, K. J. Postictal neurogenic stunned myocardium. Neurology 64, 1977–1978 (2005).
Keilson, M. J., Hauser, W. A., Magrill, J. P. & Goldman, M. ECG abnormalities in patients with epilepsy. Neurology 37, 1624–1626 (1987).
Drake, M. E., Reider, C. R. & Kay, A. Electrocardiography in epilepsy patients without cardiac symptoms. Seizure 2, 63–65 (1993).
Nei, M., Ho, R. T. & Sperling, M. R. EKG abnormalities during partial seizures in refractory epilepsy. Epilepsia 41, 542–548 (2000).
Tigaran, S. Cardiac abnormalities in patients with refractory epilepsy. Acta Neurol. Scand. Suppl. 177, 9–32 (2002).
Engel, G. et al. Electrocardiographic arrhythmia risk testing. Curr. Probl. Cardiol. 29, 365–432 (2004).
Surges, R. et al. Pathological cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: a case-control study. Epilepsia (in press).
Akalin, F., Tirtir, A. & Yilmaz, Y. Increased QT dispersion in epileptic children. Acta Paediatr. 92, 916–920 (2003).
Keilson, M. J., Hauser, W. A. & Magrill, J. P. Electrocardiographic changes during electrographic seizures. Arch. Neurol. 46, 1169–1170 (1989).
Galimberti, C. A. et al. Partial epileptic seizures of different origin variably affect cardiac rhythm. Epilepsia 37, 742–747 (1996).
Opherk, C., Coromilas, J. & Hirsch, L. J. Heart rate and EKG changes in 102 seizures: analysis of influencing factors. Epilepsy Res. 52, 117–127 (2002).
Zijlmans, M., Flanagan, D. & Gotman, J. Heart rate changes and ECG abnormalities during epileptic seizures: prevalence and definition of an objective clinical sign. Epilepsia 43, 847–854 (2002).
Nei, M. et al. EEG and ECG in sudden unexplained death in epilepsy. Epilepsia 45, 338–345 (2004).
Tigaran, S., Mølgaard, H., McClelland, R., Dam, M. & Jaffe, A. S. Evidence of cardiac ischemia during seizures in drug refractory epilepsy patients. Neurology 60, 492–495 (2003).
Alehan, F. et al. Elevated CK-MB mass and plasma brain-type natriuretic peptide concentrations following convulsive seizures in children and adolescents: possible evidence of subtle cardiac dysfunction. Epilepsia 50, 755–760 (2009).
Woodruff, B. K. et al. Cardiac troponin levels following monitored epileptic seizures. Neurology 60, 1690–1692 (2003).
Mameli, O. et al. Analysis of central cardioarrhythmogenic triggers in experimental epilepsy. Epilepsy Res. 7, 210–218 (1990).
Leung, H., Schindler, K., Kwan, P. & Elger, C. Asystole induced by electrical stimulation of the left cingulate gyrus. Epileptic Disord. 9, 77–81 (2007).
Nashef, L. et al. Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy. J. Neurol. Neurosurg. Psychiatry 60, 297–300 (1996).
Lindholm, P., Nordh, J. & Linnarsson, D. Role of hypoxemia for the cardiovascular responses to apnea during exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, 1227–1235 (2002).
Schernthaner, C., Lindinger, G., Pötzelberger, K., Zeiler, K. & Baumgartner, C. Autonomic epilepsy–the influence of epileptic discharges on heart rate and rhythm. Wien. Klin. Wochenschr. 111, 392–401 (1999).
Rugg-Gunn, F. J., Simister, R. J., Squirrell, M., Holdright, D. R. & Duncan, J. S. Cardiac arrhythmias in focal epilepsy: a prospective long-term study. Lancet 364, 2212–2219 (2004).
Rocamora, R., Kurthen, M., Lickfett, L., Von Oertzen, J. & Elger, C. E. Cardiac asystole in epilepsy: clinical and neurophysiologic features. Epilepsia 44, 179–185 (2003).
Schuele, S. U. et al. Video-electrographic and clinical features in patients with ictal asystole. Neurology 69, 434–441 (2007).
Schuele, S. U., Bermeo, A. C., Locatelli, E., Burgess, R. C. & Lüders, H. O. Ictal asystole: a benign condition? Epilepsia 49, 168–171 (2008).
Schraeder, P. L. & Lathers, C. M. Cardiac neural discharge and epileptogenic activity in the cat: an animal model for unexplained death. Life Sci. 32, 1371–1382 (1983).
Mameli, O., Caria, M. A., Pintus, A., Padua, G. & Mameli, S. Sudden death in epilepsy: an experimental animal model. Seizure 15, 275–287 (2006).
Sakamoto, K. et al. Autonomic consequences of kainic acid-induced limbic cortical seizures in rats: peripheral autonomic nerve activity, acute cardiovascular changes, and death. Epilepsia 49, 982–996 (2008).
Delgado, J. M., Mihailovic, L. & Sevillano, M. Cardiovascular phenomena during seizure activity. J. Nerv. Ment. Dis. 130, 477–487 (1960).
Oppenheimer, S. M., Wilson, J. X., Guiraudon, C. & Cechetto, D. F. Insular cortex stimulation produces lethal cardiac arrhythmias: a mechanism of sudden death? Brain Res. 550, 115–121 (1991).
Oppenheimer, S. Cerebrogenic cardiac arrhythmias: cortical lateralization and clinical significance. Clin. Auton. Res. 16, 6–11 (2006).
O'Regan, M. E. & Brown, J. K. Abnormalities in cardiac and respiratory function observed during seizures in childhood. Dev. Med. Child Neurol. 47, 4–9 (2005).
Morita, H., Wu, J. & Zipes, D. P. The QT syndromes: long and short. Lancet 372, 750–763 (2008).
Kändler, L. et al. Early post-convulsive prolongation of QT time in children. Acta Paediatr. 94, 1243–1247 (2005).
Tavernor, S. J., Brown, S. W., Tavernor, R. M. & Gifford, C. Electrocardiograph QT lengthening associated with epileptiform EEG discharges—a role in sudden unexplained death in epilepsy? Seizure 5, 79–83 (1996).
Kiely, D. G., Cargill, R. I. & Lipworth, B. J. Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans. Chest 109, 1215–1221 (1996).
Roche, F. et al. Effect of acute hypoxia on QT rate dependence and corrected QT interval in healthy subjects. Am. J. Cardiol. 91, 916–919 (2003).
Simon, R. P., Aminoff, M. J. & Benowitz, N. L. Changes in plasma catecholamines after tonic-clonic seizures. Neurology 34, 255–257 (1984).
Lee, S. et al. Effects of adrenaline and potassium on QTc interval and QT dispersion in man. Eur. J. Clin. Invest. 33, 93–98 (2003).
Schimpf, R., Borggrefe, M. & Wolpert, C. Clinical and molecular genetics of the short QT syndrome. Curr. Opin. Cardiol. 23, 192–198 (2008).
Extramiana, F. & Antzelevitch, C. Amplified transmural dispersion of repolarization as the basis for arrhythmogenesis in a canine ventricular-wedge model of short-QT syndrome. Circulation 110, 3661–3666 (2004).
Arrowood, J. A. et al. Modulation of the QT interval: effects of graded exercise and reflex cardiovascular stimulation. J. Appl. Physiol. 75, 2217–2223 (1993).
Holbrook, M., Malik, M., Shah, R. R. & Valentin, J. P. Drug induced shortening of the QT/QTc interval: an emerging safety issue warranting further modelling and evaluation in drug research and development? J. Pharmacol. Toxicol. Methods 59, 21–28 (2009).
Lipka, K. & Bülow, H. H. Lactic acidosis following convulsions. Acta Anaesthesiol. Scand. 47, 616–618 (2003).
Espinosa, P. S., Lee, J. W., Tedrow, U. B., Bromfield, E. B. & Dworetzky, B. A. Sudden unexpected near death in epilepsy: malignant arrhythmia from a partial seizure. Neurology 72, 1702–1703 (2009).
Kennebäck, G., Ericson, M., Tomson, T. & Bergfeldt, L. Changes in arrhythmia profile and heart rate variability during abrupt withdrawal of antiepileptic drugs. Implications for sudden death. Seizure 6, 369–375 (1997).
Hennessy, M. J., Tighe, M. G., Binnie, C. D. & Nashef, L. Sudden withdrawal of carbamazepine increases cardiac sympathetic activity in sleep. Neurology 57, 1650–1654 (2001).
George, J. R. & Davis, G. G. Comparison of anti-epileptic drug levels in different cases of sudden death. J. Forensic Sci. 43, 598–603 (1998).
Opeskin, K., Burke, M. P., Cordner, S. M. & Berkovic, S. F. Comparison of antiepileptic drug levels in sudden unexpected deaths in epilepsy with deaths from other causes. Epilepsia 40, 1795–1798 (1999).
Boesen, F., Andersen, E. B., Jensen, E. K. & Ladefoged, S. D. Cardiac conduction disturbances during carbamazepine therapy. Acta Neurol. Scand. 68, 49–52 (1983).
Surges, R., Volynski, K. E. & Walker, M. C. Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited. Ther. Adv. Neurol. Disord. 1, 13–24 (2008).
Saetre, E. et al. Cardiac function and antiepileptic drug treatment in the elderly: A comparison between lamotrigine and sustained-release carbamazepine. Epilepsia doi:10.1111/j.1528–11672009.0 2069.x.
Danielsson, B. R., Lansdell, K., Patmore, L. & Tomson, T. Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents. Epilepsy Res. 63, 17–25 (2005).
Schouten, E. G. et al. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 84, 1516–1523 (1991).
Aurlien, D., Taubøll, E. & Gjerstad, L. Lamotrigine in idiopathic epilepsy—increased risk of cardiac death? Acta Neurol. Scand. 115, 199–203 (2007).
Dixon, R. et al. Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects. Br. J. Clin. Pharmacol. 66, 396–404 (2008).
DeSilvey, D. L. & Moss, A. J. Primidone in the treatment of the long QT syndrome: QT shortening and ventricular arrhythmia suppression. Ann. Intern. Med. 93, 53–54 (1980).
Cheng-Hakimian, A., Anderson, G. D. & Miller, J. W. Rufinamide: pharmacology, clinical trials, and role in clinical practice. Int. J. Clin. Pract. 60, 1497–1501 (2006).
Jawad, S., Mercer, A., Jamil, N. & Richens, A. Haematological values of epileptic patients entering drug trials. Int. J. Clin. Pharmacol. Res. 8, 363–366 (1988).
Hauser, E., Seidl, R., Freilinger, M., Male, C. & Herkner, K. Hematologic manifestations and impaired liver synthetic function during valproate monotherapy. Brain Dev. 18, 105–109 (1996).
Yuen, A. W. et al. Erythrocyte and plasma fatty acid profiles in patients with epilepsy: does carbamazepine affect omega-3 fatty acid concentrations? Epilepsy Behav. 12, 317–323 (2008).
Aurlien, D., Leren, T. P., Taubøll, E. & Gjerstad, L. New SCN5A mutation in a SUDEP victim with idiopathic epilepsy. Seizure 18, 158–160 (2009).
Pacia, S. V., Devinsky, O., Luciano, D. J. & Vazquez, B. The prolonged QT syndrome presenting as epilepsy: a report of two cases and literature review. Neurology 44, 1408–1410 (1994).
Johnson, J. N. et al. Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology 72, 224–231 (2009).
Berilgen, M. S., Sari, T., Bulut, S. & Mungen, B. Effects of epilepsy on autonomic nervous system and respiratory function tests. Epilepsy Behav. 5, 513–516 (2004).
Scorza, F. A. et al. Quantification of respiratory parameters in patients with temporal lobe epilepsy. Arq. Neuropsiquiatr. 65, 450–453 (2007).
Harvey, A. S. et al. Frontal lobe epilepsy: clinical seizure characteristics and localization with ictal 99mTc-HMPAO SPECT. Neurology 43, 1966–1980 (1993).
Foldvary, N. et al. Clinical and electrographic manifestations of lesional neocortical temporal lobe epilepsy. Neurology 49, 757–763 (1997).
Kaada, B. R., Pribram, K. H. & Epstein J. A. Respiratory and vascular responses in monkeys from temporal pole, insula, orbital surface and cingulate gyrus; a preliminary report. J. Neurophysiol. 12, 347–356 (1949).
Kaada, B. R. & Jasper, H. Respiratory responses to stimulation of temporal pole, insula, and hippocampal and limbic gyri in man. AMA Arch. Neurol. Psychiatry 68, 609–619 (1952).
So, E. L., Sam, M. C. & Lagerlund, T. L. Postictal central apnea as a cause of SUDEP: evidence from near-SUDEP incident. Epilepsia 41, 1494–1497 (2000).
Tavee, J. & Morris, H. 3rd. Severe postictal laryngospasm as a potential mechanism for sudden unexpected death in epilepsy: a near-miss in an EMU. Epilepsia 49, 2113–2117 (2008).
Bateman, L. M., Li, C. S. & Seyal, M. Ictal hypoxemia in localization-related epilepsy: analysis of incidence, severity and risk factors. Brain 131, 3239–3245 (2008).
Walker, F. & Fish, D. R. Recording of respiratory parameters in patients with epilepsy. Epilepsia 38 (Suppl. 11), S41–S42 (1997).
Blum, A. S. et al. Oxygen desaturations triggered by partial seizures: implications for cardiopulmonary instability in epilepsy. Epilepsia 41, 536–541 (2000).
Leestma, J. E., Walczak, T., Hughes, J. R., Kalelkar, M. B. & Teas, S. S. A prospective study on sudden unexpected death in epilepsy. Ann. Neurol. 26, 195–203 (1989).
Lear-Kaul, K. C., Coughlin, L. & Dobersen, M. J. Sudden unexpected death in epilepsy: a retrospective study. Am. J. Forensic Med. Pathol. 26, 11–17 (2005).
Baumann, A., Audibert, G., McDonnell, J. & Mertes, P. M. Neurogenic pulmonary edema. Acta Anaesthesiol. Scand. 51, 447–455 (2007).
Darnell, J. C. & Jay, S. J. Recurrent postictal pulmonary edema: a case report and review of the literature. Epilepsia 23, 71–83 (1982).
Johnston, S. C., Horn, J. K., Valente, J. & Simon, R. P. The role of hypoventilation in a sheep model of epileptic sudden death. Ann. Neurol. 37, 531–537 (1995).
Aminoff, M. J., Simon, R. P. & Wiedemann, E. The hormonal responses to generalized tonic–clonic seizures. Brain 107, 569–578 (1984).
Meierkord, H., Shorvon, S. & Lightman, S. L. Plasma concentrations of prolactin, noradrenaline, vasopressin and oxytocin during and after a prolonged epileptic seizure. Acta Neurol. Scand. 90, 73–77 (1994).
Magnaes, B. & Nornes, H. Circulatory and respiratory changes in spontaneous epileptic seizures in man. Eur. Neurol. 12, 104–111 (1974).
Sears, C. E., Noble, P., Noble, D. & Paterson, D. J. Vagal control of heart rate is modulated by extracellular potassium. J. Auton. Nerv. Syst. 77, 164–171 (1999).
Devinsky, O., Perrine, K. & Theodore, W. H. Interictal autonomic nervous system function in patients with epilepsy. Epilepsia 35, 199–204 (1994).
Ansakorpi, H. et al. Interictal cardiovascular autonomic responses in patients with temporal lobe epilepsy. Epilepsia 41, 42–47 (2000).
Sathyaprabha, T. N. et al. Cardiac autonomic dysfunction in chronic refractory epilepsy. Epilepsy Res. 72, 49–56 (2006).
Weinand, M. E. et al. Response of human epileptic temporal lobe cortical blood flow to hyperventilation. Epilepsy Res. 21, 221–226 (1995).
Oppenheimer, S. M., Gelb, A., Girvin, J. P. & Hachinski, V. C. Cardiovascular effects of human insular cortex stimulation. Neurology 42, 1727–1732 (1992).
Van Buren, J. M. Some autonomic concomitants of ictal automatism; a study of temporal lobe attacks. Brain 81, 505–528 (1958).
Duncan, R., Patterson, J., Roberts, R., Hadley, D. M. & Bone, I. Ictal/postictal SPECT in the pre-surgical localisation of complex partial seizures. J. Neurol. Neurosurg. Psychiatry 56, 141–148 (1993).
Hascoet, J. M., Monin, P. & Vert, P. Persistence of impaired autoregulation of cerebral blood flow in the postictal period in piglets. Epilepsia 29, 743–747 (1988).
Bird, J. M., Dembny, K. A., Sandeman, D. & Butler, S. Sudden unexplained death in epilepsy: an intracranially monitored case. Epilepsia 38 (Suppl. 11), S52–S56 (1997).
Lee, M. A. EEG video recording of sudden unexpected death in epilepsy (SUDEP). Epilepsia 39 (Suppl. 6), 123–124 (1998).
McLean, B. N. & Wimalaratna, S. Sudden death in epilepsy recorded in ambulatory EEG. J. Neurol. Neurosurg. Psychiatry 78, 1395–1397 (2007).
Wieling, W. et al. Symptoms and Signs of Syncope: a review of the link between physiology and clinical clues. Brain (in press).
Saito, T., Sakamoto, K., Koizumi, K. & Stewart, M. Repeatable focal seizure suppression: a rat preparation to study consequences of seizure activity based on urethane anesthesia and reversible carotid artery occlusion. J. Neurosci. Methods 155, 241–250 (2006).
Fu, L. Y. & Moon, R. Y. Apparent life-threatening events (ALTEs) and the role of home monitors. Pediatr. Rev. 28, 203–208 (2007).
Lathers, C. M., Stauffer, A. Z., Tumer, N., Kraras, C. M. & Goldman, B. D. Anticonvulsant and antiarrhythmic actions of the beta blocking agent timolol. Epilepsy Res. 4, 42–54 (1989).
Mayer, T. & Specht, U. Propranolol in startle induced epileptic seizures. J. Neurol. Neurosurg. Psychiatry 58, 382–383 (1995).
Fischer, W. Anticonvulsant profile and mechanism of action of propranolol and its two enantiomers. Seizure 11, 285–302 (2002).
Bristow, M. R. et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 350, 2140–2150 (2004).
Tupal, S. & Faingold, C. L. Evidence supporting a role of serotonin in modulation of sudden death induced by seizures in DBA/2 mice. Epilepsia 47, 21–26 (2006).
Favale, E., Rubino, V., Mainardi, P., Lunardi, G. & Albano, C. Anticonvulsant effect of fluoxetine in humans. Neurology 45, 1926–1927 (1995).
Levine, R., Kenin, M., Hoffman, J. S. & Day-Knepple, E. Grand mal seizures associated with the use of fluoxetine. J. Clin. Psychopharmacol. 14, 145–146 (1994).
Nemeroff, C. B., DeVane, C. L. & Pollock, B. G. Newer antidepressants and the cytochrome P450 system. Am. J. Psychiatry 153, 311–320 (1996).
Brodie, M. J. & Holmes, G. L. Should all patients be told about sudden unexpected death in epilepsy (SUDEP)? Pros and Cons. Epilepsia 49 (Suppl. 9), 99–101 (2008).
Tan, H. L., Hofman, N., van Langen, I. M., van der Wal, A. C. & Wilde, A. A. Sudden unexplained death: heritability and diagnostic yield of cardiologic and genetic examination in surviving relatives. Circulation 112, 207–213 (2005).
Doherty, M. J. The sudden death of Patsy Custis, or George Washington on sudden unexplained death in epilepsy. Epilepsy Behav. 5, 598–600 (2004).
Williams, J. et al. Variability of antiepileptic medication taking behaviour in sudden unexplained death in epilepsy: hair analysis at autopsy. J. Neurol. Neurosurg. Psychiatry 77, 481–484 (2006).
Jick, S. S., Cole, T. B., Mesher, R. A., Tennis, P. & Jick, H. Sudden unexplained death in young persons with primary epilepsy. Pharmacoepidemiol. Drug Safety 1, 59–64 (1992).
Acknowledgements
R. Surges and J. W. Sander are based at University College London (UCL) and UCL Hospitals NHS Trust, which receive a proportion of their funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. J. W. Sander is partly supported by the Marvin Weil Epilepsy Research Fund. R. D. Thijs is supported by the Dutch Epilepsy Foundation. H. L. Tan is supported by the Royal Netherlands Academy of Arts and Sciences and the Netherlands Organization for Scientific Research (grant ZonMW-Vici 918.86.616). Charles P. Vega, University of California, Irvine, CA is the author of and is solely responsible for the content of the learning objectives, questions and answers of the MedscapeCME-accredited continuing medical education activity associated with this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Surges, R., Thijs, R., Tan, H. et al. Sudden unexpected death in epilepsy: risk factors and potential pathomechanisms. Nat Rev Neurol 5, 492–504 (2009). https://doi.org/10.1038/nrneurol.2009.118
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2009.118
This article is cited by
-
Inzidenz des plötzlichen Epilepsietodes (SUDEP): Update und Limitationen
Der Nervenarzt (2024)
-
Caffeine exacerbates seizure-induced death via postictal hypoxia
Scientific Reports (2023)
-
Circular RNAs: Diagnostic and Therapeutic Perspectives in CNS Diseases
Current Medical Science (2023)
-
Blood pressure, body mass index lowering and ketogenesis in Qigong Bigu
Acta Epileptologica (2021)
-
Autonomic manifestations of epilepsy: emerging pathways to sudden death?
Nature Reviews Neurology (2021)